Biogen: The Drug Spearheading the Fight Against Alzheimer’s
Alzheimer’s affects nearly 50 million people worldwide. As humans are living longer this number is targeted to reach 135 million by 2050. Unfortunately, a cure for Alzheimer’s has yet to be found. In recent years, however, Biogen has been pioneering studies that were more successful than those of other pharmaceutical competitors in the fight to slow the progression of …